UNS Share Price

Open 0.00 Change Price %
High 0.01 1 Day 0.00 0.00
Low 0.00 1 Week 0.00 0.00
Close 0.00 1 Month 0.00 0.00
Volume 1785053 1 Year -0.06 -100.00
52 Week High 0.07
52 Week Low 0.00
UNS Important Levels
Resistance 2 0.01
Resistance 1 0.01
Pivot 0.00
Support 1 -0.01
Support 2 -0.01
ASX Australia Most Active Stocks
LYC 0.15 7.14%
TLS 3.90 0.78%
TLS 3.90 0.78%
TLS 3.90 0.78%
PCL 0.00 0.00%
PCL 0.00 0.00%
DUE 3.02 1.00%
DUE 3.02 1.00%
BUR 0.02 0.00%
BUR 0.02 0.00%
ASX Australia Top Gainers Stocks
KSO 0.40 3900.00%
VKA 0.02 100.00%
CAV 0.02 100.00%
CAV 0.02 100.00%
GMD 0.02 100.00%
GMD 0.02 100.00%
RDS 0.02 100.00%
RDS 0.02 100.00%
RDS 0.02 100.00%
AZZ 0.50 78.57%
ASX Australia Top Losers Stocks
NME 0.00 -100.00%
NME 0.00 -100.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
TCQ 0.27 -73.53%
GDY 0.01 -50.00%
AZS 0.01 -50.00%
AZS 0.01 -50.00%

Unilife Corp (ASX: UNS)

UNS Technical Analysis 5
As on 12th Apr 2017 UNS Share Price closed @ 0.00 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.07 & Strong Sell for SHORT-TERM with Stoploss of 0.04 we also expect STOCK to react on Following IMPORTANT LEVELS.
UNS Target for August
1st Target up-side N/A
2nd Target up-side N/A
3rd Target up-side N/A
1st Target down-side N/A
2nd Target down-side N/A
3rd Target down-side N/A
UNS Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Medical Instruments & Supplies
Offical website http://www.unilife.com
UNS Address
250 Cross Farm Lane
York, PA 17406
United States
Phone: 717-384-3400
Fax: 717-384-3401
UNS Latest News
Share Activity Lifted for Unilife Corporation (UNISQ) in Session   Melville Review   - 18th Aug 17
SSG Advises Unilife Corporation in the Sale of its Assets to OrbiMed and Amgen   ABL Advisor   - 17th Aug 17
Unilife Committee Atty Withdraws To Save Firm's Retention   Law360 (subscription)   - 11th Jul 17
Unilife, Competitor Spar Over Ch. 11 Sale Doc Access   Law360 (subscription)   - 22nd Jun 17
Delisting of Securities of Gordmans Stores, Inc., Unilife Corporation, Osiris ...   GlobeNewswire (press release)   - 28th Apr 17
Unilife Corp. files for bankruptcy   ModernHealthcare.com   - 17th Apr 17
Unilife Files for Chapter 11 Protection   PR Newswire (press release)   - 12th Apr 17
Unilife lays off 51, considers bankruptcy   York Daily Record/Sunday News   - 06th Apr 17
Unilife -66% on dire financial warning   Seeking Alpha   - 05th Apr 17
Unilife Announces Filing of 2016 10-K   PR Newswire (press release)   - 24th Oct 16
Interactive Technical Analysis Chart Unilife Corp ( UNS ASX Australia )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Unilife Corp
UNS Business Profile
Unilife Corporation designs, develops, manufactures, and commercializes injectable drug delivery systems in the United States and internationally. The company offers Unifill Syringe, a staked (fixed) retracting needle that is designed for use with liquid stable drugs; Unifill Select for use of liquid stable drug or vaccine, or a diluent to reconstitute and deliver a lyophilized drug supplied in a vial; and Unifill Assure, a finger flange and a thumb press for the intuitive self-injection of biologics. It also provides Rita disposable auto-injector that is designed to inject the prefilled dose from a single Unifill syringe; and Lisa reusable auto-injector, which automates the removal of the needle shield and enhances needle insertion and retraction, as well as EZMix dual or multi-chamber prefilled syringe for the reconstitution and delivery of injectable therapies. In addition, the company offers the Ocu-ject, a device for the delivery of microliter sized doses of drugs; and Depot-ject, a device that is designed to enable the precise placement of a drug depot into the vitreous of the eye, as well as Micro-ject, a device for optimizing the delivery of drugs with microliter doses that are unsuited to conventional device technologies. Its customers include pharmaceutical and biotechnology companies. The company is headquartered in York, Pennsylvania.